Table 4.

Cell apoptosis at prostate adenocarcinoma and benign prostatic hyperplasia cases reported to control cases.

Number	Parameters	Control X ± SD	PCa X ± SD	Control X ± SD	BPH X ± SD
1	Viability	86.95 ± 5.75	81.30 ± 16.42	86.95 ± 5.75 *	64.26 ± 22.68 *
	p values	0.396		0.037
2	Necrosis	13.04 ± 5.76	8.56 ± 13.40	13.04 ± 5.76 *	26.76 ± 6.32 *
	p values	0.470		0.030
3	Incipient apoptosis	0.10 ± 0.01 *	7.08 ± 10.46 *	0.10 ± 0.01	6.67 ± 10.14
	p values	0.025		0.105
4	Late apoptosis	0.00 ± 0.00	2.96 ± 6.55	0.00 ± 0.00	2.28 ± 5.58
	p values	0.115		0.286

Legend: X, obtained results mean; SD, standard deviation; PCa, prostate adenocarcinoma; BPH, benign prostatic hyperplasia; IA, incipient apoptosis; LA, late apoptosis; * p < 0.05 represents a statistically significant difference between controls and experimental samples made by independent t test.